{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:29:11Z","timestamp":1792114151179,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-14-0006136"],"award-info":[{"award-number":["G-14-0006136"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["ID \\u2013 313156"],"award-info":[{"award-number":["ID \\u2013 313156"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtha.2023.10.028","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:53:17Z","timestamp":1699501997000},"page":"727-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Joseph R.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Abdulrehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffan Frosi","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"St John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Spyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.10.028_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.028_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.10.028_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.thromres.2022.09.014","article-title":"Cancer and stroke: what do we know and where do we go?","volume":"219","author":"Lun","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.10.028_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","article-title":"Insights into onco-cardiology: atrial fibrillation in cancer","volume":"63","author":"Farmakis","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2023.10.028_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jamacardio.2016.0280","article-title":"Risk of malignant cancer among women with new-onset atrial fibrillation","volume":"1","author":"Conen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jtha.2023.10.028_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaccao.2022.08.005","article-title":"Evaluating anticoagulant strategies for atrial fibrillation in patients with cancer: challenges and opportunities","volume":"4","author":"Siegal","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2023.10.028_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ehjqcco\/qcx004","article-title":"Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry","volume":"3","author":"Melloni","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jtha.2023.10.028_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/phar.2350","article-title":"Oral anticoagulant prescription trends, profile use, and determinants of adherence in patients with atrial fibrillation","volume":"40","author":"Perreault","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jtha.2023.10.028_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11239-022-02727-0","article-title":"Trends in utilization, reimbursement, and price for DOACs and warfarin in the US Medicaid population from 2000 to 2020","volume":"55","author":"Costa","year":"2023","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.10.028_bib10","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.028_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0039-3400300","article-title":"Efficacy and safety of nonvitamin K oral anticoagulants in patients with atrial fibrillation and cancer: a study-level meta-analysis","volume":"120","author":"Cavallari","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib12","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3324\/haematol.13055","article-title":"Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry","volume":"93","author":"Prandoni","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.10.028_bib13","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.028_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25227","article-title":"Ischemic stroke in cancer patients: a review of an underappreciated pathology","volume":"83","author":"Navi","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jtha.2023.10.028_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","article-title":"Cancer and embolic stroke of undetermined source","volume":"52","author":"Navi","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2023.10.028_bib16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2023.10.028_bib17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.028_bib18","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians Clinical Practice Guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.10.028_bib19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2023.10.028_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/jth.14468","article-title":"Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: an analysis of thrombotic and bleeding outcomes","volume":"17","author":"Shaw","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jtha.2022.12.016","article-title":"Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer","volume":"21","author":"Aziz","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib22","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/annonc\/mds058","article-title":"Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients","volume":"23","author":"Tafur","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtha.2023.10.028_bib23","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1111\/jth.15896","article-title":"Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH","volume":"20","author":"Wang","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib24","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1160\/TH17-08-0553","article-title":"The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for patients on a direct oral anticoagulant who need an elective surgery or procedure: design and rationale","volume":"117","author":"Douketis","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib25","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib26","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jtha.2023.10.028_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib28","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib29","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/bloodadvances.2020002335","article-title":"Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure","volume":"4","author":"Shaw","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.10.028_bib30","article-title":"Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study","volume":"9","author":"Tafur","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2023.10.028_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ahj.2017.09.015","article-title":"Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: analysis of the BRIDGE trial","volume":"195","author":"Clark","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2023.10.028_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12630-021-02165-1","article-title":"The association of thrombin generation with bleeding outcomes in cardiac surgery: a prospective observational study","volume":"69","author":"Bartoszko","year":"2022","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jtha.2023.10.028_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100031","article-title":"Viscoelastic testing: an illustrated review of technology and clinical applications","volume":"7","author":"Hartmann","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtha.2022.11.029","article-title":"DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature","volume":"21","author":"Shaw","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.028_bib35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.028_bib36","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1111\/jth.15901","article-title":"Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure","volume":"20","author":"Shaw","year":"2022","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623008309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623008309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:27:02Z","timestamp":1778617622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623008309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1538783623008309"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.028","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}